FIFTH THIRD BANCORP
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 35527
CINCINNATI, OH
Position in VRTX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$39,518,343
+$29,472,793 QoQ
Shares Held
88,499
+299.4% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 57.95432716753862.ToString("F0")%
Shared 0.ToString("F0")%
None 42.045672832461385.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIFTH THIRD BANCORP holds $165,893,632 across 150 Biotechnology names. VRTX ranks #1 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
88,499 | $39,518,343 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
34,910 | $26,972,862 | |
| 3 | VCEL |
Vericel Corp
|
256,688 | $8,257,652 | |
| 4 | LCTX |
Lineage Cell Therapeutics, Inc.
|
4,600,000 | $7,268,000 | |
| 5 | TECH |
BIO-TECHNE Corp
|
136,521 | $7,134,587 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
63,800 | $5,370,046 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
68,128 | $4,403,112 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
51,238 | $4,267,613 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,518,343 | 88,499 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $10,045,550 | 22,158 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $8,703,415 | 22,223 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $10,784,524 | 24,224 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $12,512,719 | 25,809 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $10,511,678 | 26,103 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $12,575,763 | 27,040 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $12,478,263 | 26,622 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $11,178,005 | 26,741 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $11,009,222 | 27,057 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $9,575,020 | 27,535 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $9,668,727 | 27,475 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $9,154,043 | 29,054 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $7,645,161 | 26,474 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $7,263,689 | 25,087 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $6,303,924 | 22,371 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $5,211,570 | 19,970 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $3,496,690 | 15,923 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $3,093,243 | 17,053 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $4,426,181 | 21,952 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $16,486,360 | 76,720 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $20,459,481 | 86,568 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $15,226,746 | 55,956 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $11,639,398 | 40,093 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,331,806 | 5,597 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||